97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

687 trials found

diseases per page:

Showing 1 to 10 of 687 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05442567 (ClinicalTrials.gov)	May 2, 2023	30/6/2022	A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD ...	A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric ...	Ulcerative Colitis;Crohn's Disease	Drug: Vedolizumab IV;Other: No Intervention	Takeda	NULL	Not yet recruiting	3 Years	17 Years	All	240	Phase 3	NULL
2	NCT05117749 (ClinicalTrials.gov)	May 2023	21/10/2021	Saffron and Ulcerative Colitis	The Effect of Saffron in Patients With Ulcerative Colitis: A Randomized Double-blind Clinical Trial	Ulcerative Colitis	Drug: Saffron 100;Drug: Saffron 50;Drug: Placebo	Shiraz University of Medical Sciences	NULL	Not yet recruiting	18 Years	80 Years	All	60	Phase 2	NULL
3	NCT05771155 (ClinicalTrials.gov)	May 2023	1/3/2023	Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With ...	A Randomized, Double-blind, Multicenter Phase 3 Study in Patients With Moderately to Severely Active ...	Ulcerative Colitis	Biological: Intravenous (IV) infusions	Polpharma Biologics S.A.	NULL	Not yet recruiting	18 Years	75 Years	All	750	Phase 3	NULL
4	NCT05370885 (ClinicalTrials.gov)	May 2023	30/3/2022	VE202 in Patients With Mild-to-Moderate Ulcerative Colitis	Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients With Mild-to-Modera ...	Ulcerative Colitis;Colitis, Ulcerative	Biological: VE202;Drug: Vancomycin Oral Capsule;Other: VE202 Placebo;Other: Vancomycin Placebo	Vedanta Biosciences, Inc.	NULL	Not yet recruiting	18 Years	75 Years	All	100	Phase 2	NULL
5	NCT05672199 (ClinicalTrials.gov)	April 26, 2023	3/1/2023	Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active ...	A Phase 2 Long-Term Extension (LTE) Study to Evaluate The Safety and Efficacy of Efavaleukin Alfa in ...	Ulcerative Colitis	Drug: Efavaleukin alfa;Drug: Placebo	Amgen	NULL	Not yet recruiting	18 Years	80 Years	All	200	Phase 2	NULL
6	NCT05767021 (ClinicalTrials.gov)	April 21, 2023	8/2/2023	A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Col ...	A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relations ...	Ulcerative Colitis Chronic;Ulcerative Colitis	Drug: Mirikizumab	Eli Lilly and Company	NULL	Not yet recruiting	18 Years	N/A	All	160	Phase 3	NULL
7	NCT05702879 (ClinicalTrials.gov)	April 1, 2023	18/1/2023	Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy ...	An Early Combined Microbiota and Metabolic Signature in Ulcerative Colitis Patients Predict the Clin ...	Ulcerative Colitis	Drug: Ozanimod;Drug: TNF Inhibitor;Drug: Steroids;Drug: Vedolizumab;Drug: Ustekinumab	University Hospital Inselspital, Berne	Bristol-Myers Squibb	Not yet recruiting	18 Years	80 Years	All	240		NULL
8	NCT05715099 (ClinicalTrials.gov)	March 30, 2023	19/1/2023	Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease	Efficacy of Nutritional Saffron Supplement as an Anti-inflammatory Agent in Egyptian Patients With I ...	Ulcerative Colitis	Drug: Saffron;Drug: Placebo	Minia University	NULL	Not yet recruiting	18 Years	60 Years	All	90	Phase 4	Egypt
9	NCT05770609 (ClinicalTrials.gov)	March 15, 2023	5/3/2023	A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel, Dose-finding Phase II Clinica ...	Mild to Moderate Ulcerative Colitis	Drug: SPH3127 Tablets with Dose A;Drug: SPH3127 Tablets with Dose B;Drug: SPH3127 Tablets placebo	Shanghai Pharmaceuticals Holding Co., Ltd	NULL	Not yet recruiting	18 Years	75 Years	All	108	Phase 2	China
10	NCT04314375 (ClinicalTrials.gov)	March 2023	17/3/2020	Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets ...	A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Efficacy, ...	Ulcerative Colitis	Drug: Low Dose Budesonide;Drug: High Dose Budesonide;Drug: Placebo	Bausch Health Americas, Inc.	NULL	Not yet recruiting	5 Years	17 Years	All	70	Phase 4	NULL

First Previous1 2 3 4 5…69Next Last